CDK5 and Alzheimer disease: In support of a role for CRMP2 in neurodegenerative pathways, previous studies have revealed that CRMP2 is hyperphosphorylated as a result of abnormal CDK5 activity in the brains of AD patients and in a transgenic mouse model of AD [20].